Trials / Completed
CompletedNCT04700293
Tolerance and Acceptability Evaluation of AYMES AMSTERDAM
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Aymes International Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate tolerance and acceptability of 'AMSTERDAM' in patients requiring supplementary oral nutritional support compared with currently available alternatives.
Detailed description
To evaluate tolerance and acceptability of 'AMSTERDAM' in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference, convenience etc. To obtain data to support an ACBS submissions for 'AMSTERDAM' (to allow for prescription in the community at NHS expense).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AYMES AMSTERDAM | AYMES AMSTERDAM is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition. |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2021-01-07
- Last updated
- 2021-01-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04700293. Inclusion in this directory is not an endorsement.